The bill extends explicit Medicare coverage (and potential cost savings) for medically necessary cranial prostheses, improving access for beneficiaries with hair loss, but creates new paperwork and potential coverage gaps for patients without access to certifying providers or with improperly completed certifications.
Medicare beneficiaries with medically caused hair loss (e.g., from cancer/chemotherapy or autoimmune disease) gain explicit Medicare coverage for cranial prostheses when a clinician certifies medical necessity.
Medicare beneficiaries who receive a certified cranial prosthesis can face lower out-of-pocket costs because Medicare is authorized to pay for the item as durable medical equipment (DME).
Clinicians and CMS get a clear documentation pathway (written certification) that may streamline claims processing and clarify coverage determinations when the required certification is provided.
Medicare beneficiaries who lack access to the listed certifying providers may be denied coverage for cranial prostheses and face higher out-of-pocket costs for wigs.
Clinicians and suppliers will face added administrative burden to obtain and retain written certifications, which could delay access to prostheses for patients.
If required certifications are not properly completed, Medicare payments are explicitly prohibited, potentially increasing uncompensated costs for patients or providers.
Based on analysis of 2 sections of legislative text.
Adds cranial prostheses (wigs) to Medicare durable medical equipment when a qualifying physician certifies they are medically necessary; missing certification allows denial of payment.
Introduced February 12, 2026 by James P. McGovern · Last progress February 12, 2026
Adds cranial prostheses (wigs) to the list of items Medicare can treat as durable medical equipment when a dermatologist, oncologist, or the attending physician provides a written certification that the prosthesis is medically necessary for rehabilitative treatment or for hair loss caused by a health condition (including autoimmune disease, cancer, or chemotherapy). It also makes the absence of that written certification an express reason for Medicare to deny payment.